Tim Heffron
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Quinazolinone synthesis and applications
Most-Cited Works
- → Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer(2010)131 cited
- → Abstract C201: A novel potent and selective inhibitor of PI3K/mTOR, GDC-0980, currently in phase I clinical trials(2009)1 cited
- → Abstract LB-309: Non-covalent wild-type-sparing inhibitors of EGFR T790M .(2013)1 cited
- → Abstract 2787: Discovery of GDC-0980, a selective PI3K/mTOR inhibitor in clinical trials(2011)